Evaluation of next generation sequencing for detecting HER2 copy number in breast and gastric cancers.

e13004Background: Amplicon-based next generation sequencing (NGS) approaches have been preferentially adopted by the clinical laboratories on the basis of a short turnaround time (TAT) and small DN...